Manejo de hemorragia asociada a anticoagulantes orales directos: estado actual de las estrategias de reversión
Direct oral anticoagulants (DOACs), including the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban have at least comparable efficacy as vitamin K antagonists along with a better safety profile, reflected by a lower incidence of intracranial...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Langue: | Spanish / Castilian |
| Publié: |
Sociedad Médica de Santiago
2019
|
| Sujets: | |
| Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000100073 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|